Diazepam neuroprotection in excitotoxic and oxidative stress involves a mitochondrial mechanism additional to the

Anna Sarnowska1, Małgorzata Beresewicz, Barbara Zabłocka

  • 1NeuroRepair Department, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland. a_sarnowska@tlen.pl

Insights

Diazepam protects hippocampal neurons from death by reducing mitochondrial cytochrome c release, not just by lowering body temperature. This neuroprotection involves GABA(A) and TSPO receptors.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Neuronal death in the CA1 hippocampus sector is a critical factor in ischemic brain injury.
  • Diazepam is known to have neuroprotective effects, but its precise mechanisms are not fully understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying diazepam's neuroprotection in CA1 hippocampal neurons.
  • To differentiate the neuroprotective effects of diazepam from drug-induced hypothermia.

Main Methods:

  • In vivo transient global ischemia model in gerbils and in vitro models using rat hippocampal slices subjected to NMDA or oxidative stress.
  • Monitoring body temperature changes and neuronal survival rates post-ischemia.
  • Assessing the effect of diazepam on cytochrome c efflux from mitochondria.

Main Results:

  • Diazepam significantly increased CA1 neuronal survival in vivo and in vitro, independent of hypothermia.
  • Neuroprotection occurred within a specific dose range (0.5-10 microM) and was observed even with GABA(A) receptor blockade.
  • Diazepam reduced cytochrome c efflux from mitochondria in stressed neurons and isolated mitochondria.

Conclusions:

  • Diazepam's neuroprotective effects extend beyond hypothermia, involving mechanisms beyond GABA(A) receptor agonism.
  • The translocator protein (TSPO) may play a role in diazepam-mediated neuroprotection.
  • Diazepam's action on mitochondrial pathways is a key component of its neuroprotective strategy.

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...